RT’s Three Key Takeaways:
- Product Launch: Fisher & Paykel Healthcare Corp has launched the F&P my820 System, a brand new respiratory humidifier designed for residence mechanical air flow.
- Options: The F&P my820 supplies heated humidification for invasive and noninvasive air flow, in addition to high-flow therapies, and adapts to environmental temperature modifications utilizing a built-in sensor.
- International Availability: The F&P my820 System is now out there in the US, Australasia, Europe, and Canada, with further markets pending regulatory clearances.
Fisher & Paykel Healthcare Corp introduced the launch of the F&P my820 System in the US.
The F&P my820 is the corporate’s newest respiratory humidifier for residence mechanical air flow. The F&P my820 System supplies heated humidification in the course of the supply of invasive air flow, noninvasive air flow, and humidified high-flow therapies for grownup and pediatric sufferers.
“The F&P my820 is the results of years of devoted funding in new applied sciences that enhance care and outcomes for sufferers of their properties,” says Andrew Somervell, vice chairman of merchandise and know-how, in a launch. “It supplies peace of thoughts that adults and youngsters can proceed to obtain high-quality care after they depart the hospital.”
Designed particularly to carry out in residence environments the place temperatures can fluctuate, the F&P my820 System routinely adapts to environmental temperature modifications utilizing a built-in sensor. This sensor works to mitigate circuit condensate whereas additionally lowering device-wire litter and offering sufferers with a simplified set-up course of.
The F&P my820 System is at the moment out there in Australasia, Europe, Canada, and the US, with extra markets being added as regulatory clearances are acquired.
Photograph caption: F&P my820
Photograph credit score: Fisher & Paykel Healthcare Corp
